GPX2 overexpression is involved in cell proliferation and prognosis of castrationresistant prostate cancer

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 1962-1967

  Naiki, Taku ^a   Naiki Ito, Aya ^a   Asamoto, Makoto ^a   Kawai, Noriyasu ^a   Tozawa, Keiichi ^a   Etani, Toshiki ^a   Sato, Shinya ^a   Suzuki, Shugo ^a   Shirai, Tomoyuki ^a   Kohri, Kenjiro ^a   Takahashi, Satoru ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MICE; MICE, NUDE; MULTIVARIATE ANALYSIS; NEOPLASM TRANSPLANTATION; NEOPLASM, RESIDUAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RATS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

CYCLIN B1; GLUTATHIONE PEROXIDASE 2; PROSTATE SPECIFIC ANTIGEN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANDROGEN DEPRIVATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROSTATECTOMY; RAT; RECURRENCE FREE SURVIVAL; REGULATORY MECHANISM; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84906841487     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu048     Document Type: Article

References (26)

1. Grönberg,H. (2003) Prostate cancer epidemiology. Lancet, 361, 859-864.
2. Jemal,A. et al. (2007) Cancer statistics, 2007. CA Cancer J. Clin., 57, 43-66.
3. Huggins,C. (1967) Endocrine-induced regression of cancers. Cancer Res., 27, 1925-1930.
4. Finkel,T. et al. (2000) Oxidants, oxidative stress and the biology of ageing. Nature, 408, 239-247.
5. Sauer,H. et al. (2001) Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem., 11, 173-186.
6. Nose,K. (2000) Role of reactive oxygen species in the regulation of physiological functions. Biol. Pharm. Bull., 23, 897-903.
7. Go,Y.M. et al. (2010) Redox control systems in the nucleus: mechanisms and functions. Antioxid. Redox Signal., 13, 489-509.
8. Chen,X.J. et al. (2005) The organization and inheritance of the mitochondrial genome. Nat. Rev. Genet., 6, 815-825.
9. Dakubo,G.D. et al. (2006) Altered metabolism and mitochondrial genome in prostate cancer. J. Clin. Pathol., 59, 10-16.
10. Ripple,M.O. et al. (1997) Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl Cancer Inst., 89, 40-48.
11. Bostwick,D.G. et al. (2000) Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer, 89, 123-134.
12. Sharifi,N. et al. (2008) Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. Clin. Cancer Res., 14, 6073-6080.
13. Khandrika,L. et al. (2009) Oxidative stress in prostate cancer. Cancer Lett., 282, 125-136.
14. Shiota,M. et al. (2010) Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. Oncogene, 29, 237-250.
15. Dalle-Donne,I. et al. (2007) S-glutathionylation in protein redox regulation. Free Radic. Biol. Med., 43, 883-898.
16. Oberley,L.W. et al. (1979) Role of superoxide dismutase in cancer: a review. Cancer Res., 39, 1141-1149.
17. Circu,M.L. et al. (2012) Glutathione and modulation of cell apoptosis. Biochim. Biophys. Acta, 1823, 1767-1777.
18. Brigelius-Flohe,R. et al. (2012) Glutathione peroxidases. Biochim. Biophys. Acta, 1830, 3289-3303.
19. Naiki,T. et al. (2012) Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice. Prostate, 72, 533-541.
20. Hokaiwado,N. et al. (2008) Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis, 29, 1134-1138.
21. Mörk,H. et al. (2003) Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus. Int. J. Cancer, 105, 300-304.
22. Mörk,H. et al. (2000) Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr. Cancer, 37, 108-116.
23. Dewa,Y. et al. (2007) Gene expression analyses of the liver in rats treated with oxfendazole. Arch. Toxicol., 81, 647-654.
24. Naiki-Ito,A. et al. (2007) Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens. Cancer Res., 67, 11353-11358.
25. Ouyang,X. et al. (2005) Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res., 65, 6773-6779.
26. Geybels,M.S. et al. (2012) Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate, 73, 734-742.